Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.380
+0.010 (0.73%)
Apr 29, 2026, 10:27 AM EDT - Market open
Allarity Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 14.69 | 19.53 | 0.17 | 2.03 | 19.56 | Upgrade
|
| Short-Term Investments | 0.08 | 0.07 | 0.06 | 0.05 | 0.4 | Upgrade
|
| Cash & Short-Term Investments | 14.77 | 19.61 | 0.22 | 2.08 | 19.96 | Upgrade
|
| Cash Growth | -24.66% | 8731.08% | -89.33% | -89.58% | 5353.01% | Upgrade
|
| Other Receivables | 0.9 | 2.23 | 0.95 | 0.87 | 1.35 | Upgrade
|
| Receivables | 0.9 | 2.23 | 0.95 | 0.87 | 1.35 | Upgrade
|
| Prepaid Expenses | 2.11 | 0.51 | 0.78 | 0.59 | 0.04 | Upgrade
|
| Other Current Assets | 0.15 | - | 0.02 | 1.43 | 0.07 | Upgrade
|
| Total Current Assets | 17.93 | 22.34 | 1.97 | 4.97 | 21.4 | Upgrade
|
| Property, Plant & Equipment | 0.33 | 0.31 | 0.02 | 0.03 | 0.09 | Upgrade
|
| Other Intangible Assets | - | - | 9.87 | 9.55 | 28.14 | Upgrade
|
| Total Assets | 18.26 | 22.65 | 11.86 | 14.54 | 49.63 | Upgrade
|
| Accounts Payable | 4.28 | 4.18 | 8.42 | 6.25 | 0.7 | Upgrade
|
| Accrued Expenses | 2.52 | 2.46 | 1.25 | 1.9 | 8.59 | Upgrade
|
| Short-Term Debt | - | - | - | 2.64 | - | Upgrade
|
| Current Portion of Long-Term Debt | 1.4 | 1.35 | 1.3 | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | 0.01 | 0.1 | Upgrade
|
| Current Income Taxes Payable | 0.08 | 0.07 | 0.06 | 0.04 | 0.06 | Upgrade
|
| Other Current Liabilities | 0.15 | 2.78 | 3.14 | 0.37 | 11.27 | Upgrade
|
| Total Current Liabilities | 8.43 | 10.84 | 14.17 | 11.22 | 20.72 | Upgrade
|
| Long-Term Debt | - | - | - | 1.08 | 0.98 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.01 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.45 | 0.35 | 1.96 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 7.18 | Upgrade
|
| Total Liabilities | 8.43 | 10.84 | 14.61 | 12.65 | 30.85 | Upgrade
|
| Common Stock | 0 | 0 | - | - | 0 | Upgrade
|
| Additional Paid-In Capital | 144.23 | 131.13 | 90.37 | 83.16 | 85.24 | Upgrade
|
| Retained Earnings | -130.2 | -118.97 | -94.45 | -82.55 | -66.49 | Upgrade
|
| Treasury Stock | -3.19 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | -1.02 | -0.35 | -0.41 | -0.72 | -0.6 | Upgrade
|
| Total Common Equity | 9.83 | 11.81 | -4.49 | -0.11 | 18.15 | Upgrade
|
| Shareholders' Equity | 9.83 | 11.81 | -2.75 | 1.89 | 18.78 | Upgrade
|
| Total Liabilities & Equity | 18.26 | 22.65 | 11.86 | 14.54 | 49.63 | Upgrade
|
| Total Debt | 1.4 | 1.35 | 1.3 | 3.74 | 1.09 | Upgrade
|
| Net Cash (Debt) | 13.37 | 18.26 | -1.08 | -1.66 | 18.87 | Upgrade
|
| Net Cash Growth | -26.76% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.93 | 11.36 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 15.82 | 17.01 | 0.01 | 0 | 0 | Upgrade
|
| Total Common Shares Outstanding | 19.03 | 7.3 | - | 0 | 0 | Upgrade
|
| Working Capital | 9.5 | 11.5 | -12.2 | -6.25 | 0.69 | Upgrade
|
| Book Value Per Share | 0.52 | 1.62 | - | -5947.37 | 1815200.00 | Upgrade
|
| Tangible Book Value | 9.83 | 11.81 | -14.36 | -9.66 | -9.98 | Upgrade
|
| Tangible Book Value Per Share | 0.52 | 1.62 | - | -508526.32 | -998300.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.